Integrative Physiology |
From the Center for Molecular Imaging Research, (M.N., D.E.S., P.W., F.K.S., A.P., E.A., J.-L.F., M.S.P., R.W.) Massachusetts General Hospital, Boston; Cardiology Division (D.E.S.), Department of Medicine, Massachusetts General Hospital Boston.
Correspondence to Ralph Weissleder, MD, PhD, MGH-CMIR, 149 13th St., Rm. 5406, Charlestown, MA 02129. E-mail Weissleder{at}helix.mgh.harvard.edu
Inflammatory responses after myocardial infarction profoundly impact tissue repair. Yet, efficient tools to serially and noninvasively assess cellular and molecular functions in postinfarct inflammation are lacking. Here we use multichannel fluorescent molecular tomography (FMT) for spatiotemporal resolution of phagocytic and proteolytic activities mediated by macrophages and neutrophils in murine infarcts. We performed FMT imaging to compare the course of efficient and impaired healing in wild-type and FXIII/ mice, respectively. Mice subjected to coronary ligation received simultaneous injections with Prosense-680, an activatable fluorescence sensor reporting on cathepsin activity, and CLIO-VT750, a magneto-fluorescent nanoparticle for imaging of phagocyte recruitment. On FMT, Prosense-680 infarct signal was 19-fold higher than background (P<0.05). Protease activity was higher in the infarcted lateral wall than in the remote, uninjured septum on ex vivo fluorescence reflectance imaging (contrast to noise ratio 118±24). CLIO-VT750 FMT signal coregistered with contrast enhancement in the hypokinetic infarct on MRI. Microscopic fluorescence signal colocalized with immunoreactive staining for cathepsin, macrophages and neutrophils. Flow cytometry of digested infarcts revealed monocytes/macrophages and neutrophils as the source of the fluorescence signal. Phagocytic activity peaked on day 6, and proteolytic activity peaked on day 4 after myocardial infarction. FMT detected impaired recruitment of phagocytes and protease activity in FXIII/ mice (P<0.05). FMT is a promising noninvasive molecular imaging approach to characterize infarct healing. Spectrally resolved imaging agents allow for simultaneous assesment of key processes of in vivo cellular functions. Specifically, we show that in vivo FMT detects impaired healing in FXIII/ mice.
Key Words: molecular imaging myocardial infarction inflammation cathepsin Factor XIII
This article has been cited by other articles:
![]() |
M. Eisenblatter, J. Ehrchen, G. Varga, C. Sunderkotter, W. Heindel, J. Roth, C. Bremer, and A. Wall In Vivo Optical Imaging of Cellular Inflammatory Response in Granuloma Formation Using Fluorescence-Labeled Macrophages J. Nucl. Med., October 1, 2009; 50(10): 1676 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Swirski, R. Weissleder, and M. J. Pittet Heterogeneous In Vivo Behavior of Monocyte Subsets in Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1424 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nahrendorf, P. Waterman, G. Thurber, K. Groves, M. Rajopadhye, P. Panizzi, B. Marinelli, E. Aikawa, M. J. Pittet, F. K. Swirski, et al. Hybrid In Vivo FMT-CT Imaging of Protease Activity in Atherosclerosis With Customized Nanosensors Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1444 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Swirski, M. Nahrendorf, M. Etzrodt, M. Wildgruber, V. Cortez-Retamozo, P. Panizzi, J.-L. Figueiredo, R. H. Kohler, A. Chudnovskiy, P. Waterman, et al. Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites Science, July 31, 2009; 325(5940): 612 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Korideck and J. D. Peterson Noninvasive Quantitative Tomography of the Therapeutic Response to Dexamethasone in Ovalbumin-Induced Murine Asthma J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 882 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Christen, M. Nahrendorf, M. Wildgruber, F. K. Swirski, E. Aikawa, P. Waterman, K. Shimizu, R. Weissleder, and P. Libby Molecular Imaging of Innate Immune Cell Function in Transplant Rejection Circulation, April 14, 2009; 119(14): 1925 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al. Multimodality Cardiovascular Molecular Imaging, Part II Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70. [Full Text] [PDF] |
||||
![]() |
M. J. Niedre, R. H. de Kleine, E. Aikawa, D. G. Kirsch, R. Weissleder, and V. Ntziachristos Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo PNAS, December 9, 2008; 105(49): 19126 - 19131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Sinusas, F. Bengel, M. Nahrendorf, F. H. Epstein, J. C. Wu, F. S. Villanueva, Z. A. Fayad, and R. J. Gropler Multimodality Cardiovascular Molecular Imaging, Part I Circ Cardiovasc Imaging, November 1, 2008; 1(3): 244 - 256. [Full Text] [PDF] |
||||
![]() |
M. J. Lipinski, K. C. Briley-Saebo, V. Mani, and Z. A. Fayad "Positive Contrast" Inversion-Recovery With Oxide Nanoparticles-Resonant Water Suppression Magnetic Resonance Imaging: A Change for the Better? J. Am. Coll. Cardiol., August 5, 2008; 52(6): 492 - 494. [Full Text] [PDF] |
||||
![]() |
L. S. Hart and W. S. El-Deiry Invincible, but Not Invisible: Imaging Approaches Toward In Vivo Detection of Cancer Stem Cells J. Clin. Oncol., June 10, 2008; 26(17): 2901 - 2910. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nahrendorf, D. Sosnovik, J. W. Chen, P. Panizzi, J.-L. Figueiredo, E. Aikawa, P. Libby, F. K. Swirski, and R. Weissleder Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury Circulation, March 4, 2008; 117(9): 1153 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nahrendorf, E. Aikawa, J.-L. Figueiredo, L. Stangenberg, S. W. van den Borne, W. M. Blankesteijn, D. E. Sosnovik, F. A. Jaffer, C.-H. Tung, and R. Weissleder Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction Eur. Heart J., February 2, 2008; 29(4): 445 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nahrendorf, H. Zhang, S. Hembrador, P. Panizzi, D. E. Sosnovik, E. Aikawa, P. Libby, F. K. Swirski, and R. Weissleder Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis Circulation, January 22, 2008; 117(3): 379 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nahrendorf, F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J.-L. Figueiredo, P. Libby, R. Weissleder, and M. J. Pittet The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions J. Exp. Med., November 26, 2007; 204(12): 3037 - 3047. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |